Navigation Links
Revised Pregnancy Counselling Item Still Flawed

AMA President, Dr Mukesh Haikerwal, said today the AMA still has serious concerns about the revised new pregnancy counselling Medicare item//, but is relieved that the new version is less likely to pose privacy concerns than the original.

The Government previously said the new Medicare item number – due to come into effect from 1 November 2006 - would be available for counselling patients who were uncertain about their pregnancy, a process that the AMA warned could allow the identification of women who were considering an abortion.

Dr Haikerwal said the wording has now been changed to allow the item to be accessed by women who are ‘concerned about a pregnancy or a pregnancy that occurred in the preceding 12 months’.

“That’s fine, as long as the term ‘concerned’ will allow a woman to see a GP for counselling about a wide range of pregnancy-related issues, not just because she may be uncertain about her pregnancy,” Dr Haikerwal said.

“There must be no breaches of privacy.”

Dr Haikerwal is now urging the Government to remove its requirement that GPs undergo additional training in ‘non-directive counselling’ before being allowed to use the item, saying the requirement is an insult to highly trained GPs.

“We’ve received no detail on what form this training would take and what it would entail,” Dr Haikerwal said.

“We object to the notion that GPs are not capable of doing something which many of them already do every day, and which they are eminently qualified and experienced to do in an unbiased way.

“GPs are well trained in, and already delivering, non-directive counselling.

“Imposing a requirement for additional training creates a disincentive for GPs to use this item number, and that would ultimately disadvantage women.”

The Government has made the item number available to all doctors, except those who have a direct pecuniary interest in services with
'"/>




Page: 1 2

Related medicine news :

1. Royal College Issues Revised Guidelines for Face Transplantation
2. Government Allot More Funds for Revised TB Program
3. Revised Cholesterol Guidelines Causes Concern Among Medical Community
4. Serum Progesterone Helps Stratify Ectopic Pregnancy Risk
5. Pregnancy Blues
6. Smoking Delays Pregnancy
7. Pregnancy should not be confined
8. Pregnancy weight linked to breast cancer
9. Pregnancy complications indicate health problems
10. Pregnancy shouldnt be dissuaded in older age
11. Ginseng Associated with Pregnancy Risks
Post Your Comments:
Other Medicine News:Health News:Company's Award-Winning Sound Enhancement Technology Proven to Provide Superior Performance Over Other Technologies; Patent Will Enhance Able Planet, LINX AUDIO Brands 2Health News:Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross and Lifetime Television Deliver 20 Million Online Petition Signatures to Capitol Hill to Urge Congress to Stop 'Drive-Through' Mastectomies 2Health News:Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross and Lifetime Television Deliver 20 Million Online Petition Signatures to Capitol Hill to Urge Congress to Stop 'Drive-Through' Mastectomies 3Health News:Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross and Lifetime Television Deliver 20 Million Online Petition Signatures to Capitol Hill to Urge Congress to Stop 'Drive-Through' Mastectomies 4Health News:Emmy(R)- and Golden Globe(R)-Nominated Actress Marcia Cross and Lifetime Television Deliver 20 Million Online Petition Signatures to Capitol Hill to Urge Congress to Stop 'Drive-Through' Mastectomies 5Health News:Specific Brain Region Governs Problem-Solving Skills 2Health News:Specific Brain Region Governs Problem-Solving Skills 3Health News:Evolutionary phenomenon in mice may explain human infertility 2Health News:A Little Regular Exercise Extends Men's Lives 2Health News:A Little Regular Exercise Extends Men's Lives 3Health News:Long Term Care Insurance Leader Offers Advice on Preventing Dementia, the Leading Cause of Care Claims 2
Breaking Medicine Technology:AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 2AdvanDx Receives FDA 510(k) Clearance for 90 Minutes PNA FISH(R) Protocol for Identifying Staphylococcal Bloodstream Pathogens 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 2OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 3OrBIT Study Long Term Results Show Sustained Therapeutic Effect of Percutaneous Tibial Nerve Stimulation at 12 Months 4Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 2Cubist Pharmaceuticals Becomes First Company to Implement Integrated Reprints Desk Document Delivery and QUOSA Scientific Literature Workflow Solution 3Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL 28R 29 25 MG and 50 MG 53550 1Watson Pharmaceuticals Receives FDA Approval for Generic Toprol XL 28R 29 25 MG and 50 MG 53550 2Uroplasty Reports First Fiscal Quarter Results 53547 1Uroplasty Reports First Fiscal Quarter Results 53547 2Uroplasty Reports First Fiscal Quarter Results 53547 3Uroplasty Reports First Fiscal Quarter Results 53547 4Uroplasty Reports First Fiscal Quarter Results 53547 5Uroplasty Reports First Fiscal Quarter Results 53547 6Uroplasty Reports First Fiscal Quarter Results 53547 7Uroplasty Reports First Fiscal Quarter Results 53547 8Uroplasty Reports First Fiscal Quarter Results 53547 9Uroplasty Reports First Fiscal Quarter Results 53547 10Uroplasty Reports First Fiscal Quarter Results 53547 11Uroplasty Reports First Fiscal Quarter Results 53547 12Uroplasty Reports First Fiscal Quarter Results 53547 13Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 1Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 2Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 3Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 4Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 5Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 6Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 7Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 8Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 9Arena Pharmaceuticals Announces Second Quarter 2009 Financial Results and Recent Developments 53544 10